HCW Biologics Inc. - ROE
HCWB
Price:
$1.09
Market Cap:
$2.27M
HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies. Its research and development efforts are focused on addressing chronic, low-grade inflammation and a spectrum of age-related diseases. The company's leading therapeutic candidates include HCW9218, an injectable immunotherapeutic designed for patients with a variety of cancers, such as pancreatic, ovarian, breast, prostate, and colorectal, as well as for pulmonary fibrosis. Another key product, HCW9302, targets autoimmune conditions like alopecia areata and various metabolic disorders. Beyond these, HCW Biologics is also developing HCW9201, a ...[Read more]
Industry
Biotechnology
IPO Date
2021-07-20
Stock Exchange
NASDAQ
Ticker
HCWB
PE Ratio
[-0.13]
ROE
[-102.39%]
Current Ratio
[0.09]
Dividend Yield
[0%]
Enterprise Value
[7.62M]
Dividend History
The ROE as of June 2026 (TTM) for HCW Biologics Inc. (HCWB) is -102.39%
According to HCW Biologics Inc.’s latest financial reports and current stock price. The company's current ROE is -102.39%. This represents a change of -110.18% compared to the average of 1.01% of the last 4 quarters.
HCW Biologics Inc. (HCWB) Historical ROE (quarterly & annually)
How has HCWB ROE performed in the past?
The mean historical ROE of HCW Biologics Inc. over the last ten years is -30.89%. The current -102.39% ROE has changed 231.48% with respect to the historical average. Over the past ten years (40 quarters), HCWB's ROE was at its highest in in the June 2025 quarter at 3.71%. The ROE was at its lowest in in the March 2024 quarter at -85.44%.
Average
-30.89%
Median
-40.15%
Minimum
-287.90%
Maximum
443.47%
HCW Biologics Inc. (HCWB) ROE by Quarter and Year
Discovering the peaks and valleys of HCW Biologics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 366.38%
Maximum Annual ROE = 443.47%
Minimum Annual Increase = -338.85%
Minimum Annual ROE = -287.90%
| Year | ROE | Change |
|---|---|---|
| 2025 | -287.90% | -164.92% |
| 2024 | 443.47% | -338.85% |
| 2023 | -185.67% | 366.38% |
| 2022 | -39.81% | 58.45% |
| 2021 | -25.13% | -37.42% |
| 2020 | -40.15% | -50.46% |
HCW Biologics Inc. (HCWB) Average ROE
How has HCWB ROE performed in the past?
The current ROE of HCW Biologics Inc. (HCWB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.03%
5-year avg
-19.01%
10-year avg
-30.89%
HCW Biologics Inc. (HCWB) ROE vs. Peers
How is HCWB’s ROE compared to its peers?
HCW Biologics Inc.’s ROE is greater than IN8bio, Inc. (-96.39%), less than NeuroSense Therapeutics Ltd. (173.60%), greater than Adial Pharmaceuticals, Inc. (-162.83%), greater than Acurx Pharmaceuticals, Inc. (-153.93%), greater than TransCode Therapeutics, Inc. (-99.39%), greater than Creative Medical Technology Holdings, Inc. (-88.50%), greater than BioCardia, Inc. (-5456.14%), less than Brainstorm Cell Therapeutics Inc. (109.21%), greater than Aprea Therapeutics, Inc. (-59.54%), greater than Aptevo Therapeutics Inc. (-198.50%),
| Company | ROE | Market cap |
|---|---|---|
| -96.39% | $14.08M | |
| 173.60% | $19.85M | |
| -162.83% | $2.50M | |
| -153.93% | $2.44M | |
| -99.39% | $4.47M | |
| -88.50% | $5.75M | |
| -5456.14% | $5.61M | |
| 109.21% | $9.49M | |
| -59.54% | $4.64M | |
| -198.50% | $10.21M |
Build a custom stock screener for HCW Biologics Inc. (HCWB) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HCW Biologics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
HCW Biologics Inc. (HCWB) and other stocks custom spreadsheet templates
The easiest way to analyze a company like HCW Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is HCW Biologics Inc.'s ROE?
How is the ROE calculated for HCW Biologics Inc. (HCWB)?
What is the highest ROE for HCW Biologics Inc. (HCWB)?
What is the 3-year average ROE for HCW Biologics Inc. (HCWB)?
What is the 5-year average ROE for HCW Biologics Inc. (HCWB)?
How does the current ROE for HCW Biologics Inc. (HCWB) compare to its historical average?